A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

NCT06431763 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Inclisiran sodium
DRUG: BPA

Sponsor

Novartis Pharmaceuticals